SAN FRANCISCO -- An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended ...

MOUNTAIN VIEW, CA--(Marketwired - Feb 3, 2015) - Hansen Medical, Inc. (NASDAQ: HNSN) -- An abstract accepted for presentation at the 40th Annual Society of Interventional Radiology (SIR) Meeting ...

Transarterial chemoembolization (TACE), a minimally invasive procedure for liver cancer, is an effective treatment strategy for patients with large, asymptomatic, or multifocal hepatocellular ...

Correlation of pain and depression with tumor extent in patients with resected pancreas cancer. Background: TACE is a widely applied management strategy for patients with HCC. Methods: Using an ...

There's a possible new standard of care on the horizon for unresectable hepatocellular carcinoma (HCC) after years of failed attempts to improve upon the outcomes of the current protocol — stand-alone ...

Hepatocellular carcinoma (HCC) poses a substantial health burden globally, with liver cancer being the fourth most common cause of cancer-related mortality worldwide. In China, where the incidence of ...

TACE/ADAM17 is a transmembranous protease that cleaves membrane-bound growth factors like EGFR ligands. TACE-dependent proteolysis is regulated by its inhibitor, tissue inhibitor of metalloproteinases ...